Immunexpress Inc.’s Post

How did two structural heart programs successfully redesign their procedural staffing model to increase access, improve care coordination and provide optimal care for patients with aortic valve disease? 📝 Download this CV Business White Paper to learn more: https://hubs.ly/Q02rFTY_0 Edwards Lifesciences

In recognition of #SepsisAwarenessMonth, we re-visit the findings from BLINGIII with Dr. Jeffery Lipman, pointing to the benefits of continuous antibiotic infusions for severe sepsis patients, calling for a reevaluation of treatment protocols to enhance patient outcomes. https://lnkd.in/ek6cqsbY

Sepsis is a life-threatening medical emergency. According to the Global Sepsis Alliance, the disease contributes to approximately one in five deaths worldwide and in the United States alone; it stands as the leading cause of death in hospitals, leading to one in three hospital fatalities.   Tune in to this important podcast episode and learn about the complexities of sepsis diagnosis, the role of lactate and procalcitonin levels, and the global health challenge it poses. Hear from experts and a sepsis survivor about the advancements in identifying and managing this critical condition. https://lnkd.in/g_b46TZs

While the severity of sepsis can be extreme, it often can be treated. As many as 80% of septic shock patients can be saved with rapid diagnosis and treatment. Report accurate results with a comprehensive portfolio for your Sepsis QC and Calibration Verification/Linearity materials. Learn more: https://hubs.ly/Q02tcC2k0

Healthcare Professionals! Equip yourself with the knowledge to support patients with rare conditions like pulmonary alveolar proteinosis (PAP). Learn more about symptoms and one simple blood test to determine if your patient has aPAP, the most common form of PAP at lung.org/PAP

Hypoglycemic agents are typically used by patients with type 2 diabetes to control their blood sugar, but some patients with kidney disease may experience dangerous adverse events! In 2021, just over 4 percent of patients who were given hypoglycemic agents in the hospital experienced an adverse event, but AHRQ's 2024 Patient Safety Chartbook shows that Hispanic patients were impacted at nearly twice that rate. Our chartbook has the data on disparities just like this, along with the tools to take action. Learn where you efforts can make the most impact. https://lnkd.in/eCD4MFY

Hypoglycemic agents are typically used by patients with type 2 diabetes to control their blood sugar, but some patients with kidney disease may experience dangerous adverse events! In 2021, just over 4 percent of patients who were given hypoglycemic agents in the hospital experienced an adverse event, but AHRQ's 2024 Patient Safety Chartbook shows that Hispanic patients were impacted at nearly twice that rate. Our chartbook has the data on disparities just like this, along with the tools to take action. Learn where you efforts can make the most impact. https://lnkd.in/eCD4MFY

Find the tools you and your healthcare system needs to make care safer

Hypoglycemic agents are typically used by patients with type 2 diabetes to control their blood sugar, but some patients with kidney disease may experience dangerous adverse events! In 2021, just over 4 percent of patients who were given hypoglycemic agents in the hospital experienced an adverse event, but AHRQ's 2024 Patient Safety Chartbook shows that Hispanic patients were impacted at nearly twice that rate. Our chartbook has the data on disparities just like this, along with the tools to take action. Learn where you efforts can make the most impact. https://lnkd.in/dDe6MNe

Hypoglycemic agents are typically used by patients with type 2 diabetes to control their blood sugar, but some patients with kidney disease may experience dangerous adverse events! In 2021, just over 4 percent of patients who were given hypoglycemic agents in the hospital experienced an adverse event, but AHRQ's 2024 Patient Safety Chartbook shows that Hispanic patients were impacted at nearly twice that rate. Our chartbook has the data on disparities just like this, along with the tools to take action. Learn where you efforts can make the most impact. https://lnkd.in/dDe6MNe